Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Trial details
- Registry ID
- NCT04906421
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)NCT04906421 | SGMT | Phase 2 | Completed | 2023-10-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |